Institutional members access full text with Ovid®

Share this article on:

COST OF PHACOVITRECTOMY VERSUS VITRECTOMY AND SEQUENTIAL PHACOEMULSIFICATION

Seider, Michael I. MD*; Michael Lahey, J. MD*,†; Fellenbaum, Paul S. MD

doi: 10.1097/IAE.0000000000000061
Original Study

Purpose: To evaluate and compare the cost of combined pars plana vitrectomy and phacoemulsification/intraocular lens implantation (phacovitrectomy) to a sequential approach to the surgical procedures for patients with an indication for vitrectomy and a visually significant cataract.

Methods: The total cost of both the combined and sequential approaches to surgery were calculated by combining the surgeon, ambulatory surgical center, and anesthesiology fees as reimbursed by Medicare. A univariate sensitivity analysis was also performed to examine the sensitivity of our estimations to changes in surgical duration.

Results: Phacovitrectomy afforded a 17% to 20% per-patient cost savings to Medicare (depending on the type of vitrectomy) compared with vitrectomy with sequential phacoemulsification. The conclusion that phacovitrectomy was less expensive than sequential surgery was robust in sensitivity analysis.

Conclusion: Phacovitrectomy seems to be significantly less costly to Medicare than a sequential approach to surgery for patients with an indication for vitrectomy and a visually significant cataract.

When indicated, phacovitrectomy costs Medicare significantly less than pars plana vitrectomy followed by phacoemulsification later.

*Department of Ophthalmology, University of California San Francisco, San Francisco, California;

Permanente Medical Group-Hayward, Hayward, California; and

Private Practice, Albany, New York.

Reprint requests: Michael I. Seider, MD, 10 Koret Way, Room K300, San Francisco, CA 94143; e-mail: seiderm@vision.ucsf.edu

None of the authors have any financial/conflicting interests to disclose.

© 2014 by Ophthalmic Communications Society, Inc.